Atlas Trials

Contiguous Stage II Adult Burkitt Lymphoma

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Contiguous Stage II Adult Burkitt Lymphoma

RecordFirmDate
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant (NCT01959477)Case Comprehensive Cancer Center2014-03-01
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)National Cancer Institute (NCI)2013-06-01
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (NCT01805037)Northwestern University2013-03-05
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015)City of Hope Medical Center2012-10-29
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies (NCT01564277)Roswell Park Cancer Institute2011-09-29
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma (NCT02037256)Barbara Ann Karmanos Cancer Institute2011-07-01
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies (NCT01273766)Wake Forest University Health Sciences2011-01-01
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant (NCT01199562)City of Hope Medical Center2010-12-01
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT01045928)Case Comprehensive Cancer Center2010-01-01
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer (NCT01044745)University of Nebraska2009-12-10
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT00891072)National Cancer Institute (NCI)2009-07-01
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00489203)Fred Hutchinson Cancer Center2007-04-01
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies (NCT00343798)Fred Hutchinson Cancer Center2006-04-01
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer (NCT00089011)Fred Hutchinson Cancer Center2004-04-01
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858)Fred Hutchinson Cancer Center2003-09-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)Fred Hutchinson Cancer Center1999-11-01

Track Contiguous Stage II Adult Burkitt Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.